Fernando Nolasco

Adult–onset minimal change nephrotic syndrome: A long–term follow–up

Fernando Nolasco, J. S. Cameron, E.F. Heywood et al. · Kidney International · 1986 · 233 citations

Glomerular Disease, Glomerulonephritis, Urology +11

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Intraglomerular T cells and monocytes in nephritis: Study with monoclonal antibodies

Fernando Nolasco, J S Cameron, B. Hartley et al. · Kidney International · 1987 · 183 citations

Inflammation, Glomerulonephritis, Clinical Immunology +12

Leukopenia in Kidney Transplant Patients With the Association of Valganciclovir and Mycophenolate Mofetil

S. Brum, Fernando Nolasco, J. B. Sousa et al. · Transplantation Proceedings · 2008 · 101 citations

Urology, Transplantation, Mycophenolate Mofetil +9